Treatment of Type 2 Diabetes with a Breakable Extended Release Gliclazide Formulation in Primary Care: The Xrise Study.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Association of Physicians of India

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 27666900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research–INdia DIABetes (ICMR–INDIAB) study

  2011cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events

  2007cited by this paper
• Quality of Diabetes Care in the Middle- and High-Income Group Populace

  2006cited by this paper
• A systematic review of adherence with medications for diabetes.

  2004cited by this paper

• Taking a Closer Look at Gliclazide – Benefits Beyond Glycemic Control

  2025cites this paper
• Metformin for the Treatment of Type 2 Diabetes in Asian Adults: A Systematic Review

  2025cites this paper
• Optimizing Type 2 Diabetes Management: The Efficacy and Safety of Gliclazide in Clinical Practice

  2025cites this paper
• Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review

  2024influential citation
• Real-world experience of treatment individualization based on fixed-dose combination of gliclazide extended release+ metformin extended release in type 2 diabetes mellitus

  2021influential citation
• The Position of Gliclazide in the Evolving Landscapes and Disease Continuum of T2DM: A Collaborative Delphi Survey-Based Consensus from India

  2021cites this paper
• Role of Gliclazide in Safely Navigating Type 2 Diabetes Mellitus Patients Towards Euglycemia: Expert opinion from India

  2021cites this paper
• Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records

  2020cites this paper
• Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment

  2019cites this paper